We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Eyes on New Product Development.
- Authors
Novack, Gary D.
- Abstract
The article presents 2014 news on ocular pharmacology and therapeutics. The U.S. Food and Drug Administration has given approval to the company Regeneron Pharmaceuticals Inc. for the drug Eylea. The drug firm Roche Pharmaceuticals Ltd. is beginning clinical trials on the drug lampalizumab for the treatment of geographic atrophy. The European Union has given approval for the drug ozudex to the company Allergan.
- Subjects
OCULAR pharmacology; UNITED States. Food &; Drug Administration; MEDICATION safety; REGENERON Pharmaceuticals Inc.; ROCHE Pharmaceuticals Ltd.
- Publication
Journal of Ocular Pharmacology & Therapeutics, 2014, Vol 30, Issue 9, p687
- ISSN
1080-7683
- Publication type
Article
- DOI
10.1089/jop.2014.1511